Skip to content

A randomized controlled trial of platelet-rich plasma therapy for female sexual dysfunction.

A randomized controlled trial of platelet-rich plasma therapy for female sexual dysfunction.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097553
Enrollment
Unknown
Registered
2025-02-20
Start date
2025-02-27
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female sexual dysfunction (FSD)

Interventions

Blank control group:No intervention measures applied.

Sponsors

West China Second Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1.Patients with a confirmed clinical and/or pathological diagnosis of FSD, following the diagnostic criteria outlined in the Chinese Expert Consensus on the Diagnosis and Treatment of Female Sexual Dysfunction (2023 edition). 2.No relevant treatment received in the past two weeks. 3.Complete clinical and pathological data, with follow-up compliance. 4.Willingness to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1.History of protein allergy. 2.Acute inflammatory phase of the genitourinary system. 3.Presence of hematologic disorders, immune dysfunction, malignancies, or other severe gynecological diseases. 4.Pregnancy. 5.Psychological or psychiatric disorders (e.g., depression) that prevent completion of follow-up. 6.Severe systemic medical conditions affecting daily life (e.g., diagnosed severe cardiovascular diseases or immune system disorders).

Design outcomes

Primary

MeasureTime frame
Female sexual function;global response;vaginal health;

Secondary

MeasureTime frame
Sexual satisfaction;Subjective patient satisfaction;adverse events;

Countries

China

Contacts

Public ContactWei Dongmei

West China Second Hospital of Sichuan University

weidongmei@scu.edu.cn+86 189 8215 0655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026